O75663
Gene name |
TIPRL |
Protein name |
TIP41-like protein |
Names |
Putative MAPK-activating protein PM10, Type 2A-interacting protein, TIP |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:261726 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
2 structures for O75663
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 5D9G | X-ray | 215 A | A/B | 16-256 | PDB |
| AF-O75663-F1 | Predicted | AlphaFoldDB |
149 variants for O75663
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
|
rs1265988654 CA343081370 |
2 | M>I | No |
ClinGen gnomAD |
|
|
rs1199162254 CA343081342 |
2 | M>K | No |
ClinGen TOPMed |
|
|
CA31454976 rs891528712 |
4 | H>N | No |
ClinGen Ensembl |
|
|
rs746172242 CA1229876 |
4 | H>Q | No |
ClinGen ExAC gnomAD |
|
|
CA1229877 rs772353524 |
8 | S>C | No |
ClinGen ExAC gnomAD |
|
|
CA1229878 rs775627089 |
8 | S>N | No |
ClinGen ExAC gnomAD |
|
|
CA1229879 rs760815085 |
8 | S>R | No |
ClinGen ExAC gnomAD |
|
|
CA343081691 rs1572426929 |
10 | H>P | No |
ClinGen Ensembl |
|
|
CA343081736 rs1572426940 TCGA novel |
12 | D>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA Ensembl |
|
rs1029481863 CA31454991 |
13 | F>I | No |
ClinGen Ensembl |
|
|
rs768711827 CA343081860 |
14 | C>F | No |
ClinGen ExAC gnomAD |
|
|
CA343081841 rs1465582648 |
14 | C>G | No |
ClinGen gnomAD |
|
|
CA1229880 rs768711827 |
14 | C>S | No |
ClinGen ExAC gnomAD |
|
|
CA343081875 rs1255865387 |
15 | F>L | No |
ClinGen TOPMed |
|
|
rs1478313027 CA343081953 |
17 | P>T | No |
ClinGen gnomAD |
|
|
rs776601529 CA1229881 |
19 | K>R | No |
ClinGen ExAC gnomAD |
|
|
rs1459479070 CA343082097 |
20 | L>M | No |
ClinGen gnomAD |
|
|
rs761839555 CA1229882 |
21 | T>A | No |
ClinGen ExAC gnomAD |
|
|
rs1350124740 CA343082136 |
21 | T>R | No |
ClinGen TOPMed gnomAD |
|
|
rs1379364925 CA343082235 |
23 | S>C | No |
ClinGen TOPMed |
|
|
CA343082276 rs1438115101 |
24 | K>N | No |
ClinGen gnomAD |
|
|
rs955676480 CA31454995 |
25 | T>S | No |
ClinGen TOPMed gnomAD |
|
|
CA31455008 rs985559103 |
26 | H>L | No |
ClinGen Ensembl |
|
|
rs1339646550 CA343082358 |
27 | I>V | No |
ClinGen gnomAD |
|
|
rs371476972 CA31455012 |
31 | A>T | No |
ClinGen Ensembl |
|
|
rs752266948 CA1229908 |
38 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1041169699 CA31457153 |
39 | E>D | No |
ClinGen TOPMed |
|
|
rs879181819 CA31457162 |
41 | H>R | No |
ClinGen Ensembl |
|
|
CA343085002 rs1160266672 |
41 | H>Y | No |
ClinGen gnomAD |
|
|
CA1229910 rs765840211 |
42 | M>K | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs765840211 CA343085020 |
42 | M>T | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA343085014 rs1211967147 |
42 | M>V | No |
ClinGen TOPMed |
|
|
CA1229911 rs750885301 |
44 | S>A | No |
ClinGen ExAC gnomAD |
|
|
CA1229912 rs758814194 |
44 | S>Y | No |
ClinGen ExAC gnomAD |
|
|
rs747323502 CA1229914 |
47 | E>A | No |
ClinGen ExAC gnomAD |
|
|
rs576096534 CA1229916 |
50 | F>L | No |
ClinGen 1000Genomes ExAC gnomAD |
|
|
rs371542831 CA1229915 |
50 | F>S | No |
ClinGen ESP ExAC gnomAD |
|
|
CA1229920 rs749206057 |
54 | V>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs770949861 CA1229921 |
55 | L>* | No |
ClinGen ExAC gnomAD |
|
|
CA1229922 rs770949861 |
55 | L>S | No |
ClinGen ExAC gnomAD |
|
|
rs1179051863 CA343085335 |
56 | R>G | No |
ClinGen gnomAD |
|
|
rs1236989574 CA343085400 |
57 | I>M | No |
ClinGen gnomAD |
|
|
CA1229923 rs759348099 |
60 | G>E | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA343085771 rs1335065339 |
68 | N>S | No |
ClinGen TOPMed |
|
|
CA1229925 rs375553827 |
70 | T>I | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
COSM207668 rs760294386 CA1229926 |
72 | A>V | Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ExAC NCI-TCGA TOPMed gnomAD |
|
CA343085932 rs1558162349 |
74 | R>K | No |
ClinGen Ensembl |
|
|
rs758938659 CA1229929 |
75 | C>R | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA343085963 rs1376312985 |
75 | C>Y | No |
ClinGen gnomAD |
|
|
CA343086024 rs1459578508 |
77 | N>K | No |
ClinGen TOPMed |
|
|
rs1030012310 CA31457228 |
78 | N>Y | No |
ClinGen TOPMed |
|
|
CA31457231 rs952993404 |
79 | Y>H | No |
ClinGen TOPMed |
|
|
CA343086403 rs1447565734 |
90 | E>K | No |
ClinGen gnomAD |
|
|
rs1311817536 CA343086449 |
92 | Q>K | No |
ClinGen gnomAD |
|
|
rs766811520 CA1229930 |
93 | E>D | No |
ClinGen ExAC gnomAD |
|
|
rs937328464 CA31457477 |
96 | T>A | No |
ClinGen TOPMed gnomAD |
|
|
CA1229948 rs61744533 |
96 | T>M | No |
ClinGen 1000Genomes ESP ExAC TOPMed gnomAD |
|
|
rs917498929 CA31457482 |
98 | G>A | No |
ClinGen TOPMed gnomAD |
|
|
CA343086843 rs776016165 |
98 | G>R | No |
ClinGen ExAC gnomAD |
|
|
rs776016165 CA1229949 |
98 | G>S | No |
ClinGen ExAC gnomAD |
|
|
CA343086869 rs1360666347 |
99 | E>D | No |
ClinGen gnomAD |
|
|
CA343086877 rs1363307956 |
100 | H>L | No |
ClinGen TOPMed |
|
|
CA343086879 rs1363307956 |
100 | H>R | No |
ClinGen TOPMed |
|
|
CA1229950 rs761244356 |
100 | H>Y | No |
ClinGen ExAC gnomAD |
|
|
CA343086897 rs1319195489 |
101 | S>C | No |
ClinGen gnomAD |
|
|
CA1229951 rs766934400 |
101 | S>P | No |
ClinGen ExAC gnomAD |
|
|
CA343086972 rs752044854 |
104 | V>F | No |
ClinGen ExAC gnomAD |
|
|
rs752044854 CA1229952 |
104 | V>I | No |
ClinGen ExAC gnomAD |
|
|
rs759942366 CA1229953 |
105 | I>M | No |
ClinGen ExAC gnomAD |
|
|
rs1487973524 CA343087045 |
107 | P>A | No |
ClinGen gnomAD |
|
|
rs148311054 CA1229957 |
116 | Y>D | No |
ClinGen ESP ExAC gnomAD |
|
| TCGA novel | 117 | K>N | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 123 | E>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 124 | S>F | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1007306829 CA31457516 |
125 | L>F | No |
ClinGen gnomAD |
|
|
CA1229958 rs753974254 |
125 | L>H | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1211303368 CA343089411 |
129 | V>I | No |
ClinGen gnomAD |
|
|
CA31460784 rs372428067 |
130 | V>I | No |
ClinGen Ensembl |
|
|
rs780921720 CA1229971 |
133 | T>A | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1377400270 CA343089502 |
133 | T>K | No |
ClinGen TOPMed |
|
|
rs761366919 CA1229972 |
134 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1229973 rs769267756 |
135 | H>P | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 135 | H>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 137 | D>A | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA343089606 rs1442373030 |
139 | E>Q | No |
ClinGen TOPMed gnomAD |
|
|
CA343089925 rs1166726533 |
150 | F>L | No |
ClinGen TOPMed |
|
|
rs1051867321 CA31460814 |
153 | V>I | No |
ClinGen TOPMed gnomAD |
|
|
CA31460835 rs767516821 |
160 | L>R | No |
ClinGen Ensembl |
|
|
CA343090205 rs1286257453 |
164 | G>E | No |
ClinGen gnomAD |
|
| TCGA novel | 167 | S>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1156680360 CA343090275 |
167 | S>R | No |
ClinGen gnomAD |
|
|
CA1229979 rs764291936 |
169 | S>R | No |
ClinGen ExAC gnomAD |
|
|
rs1423235090 CA343090432 |
172 | I>M | No |
ClinGen TOPMed |
|
|
rs757463299 CA1229981 |
172 | I>T | No |
ClinGen ExAC gnomAD |
|
|
CA343092276 rs1477742589 |
174 | V>E | No |
ClinGen gnomAD |
|
|
CA1230003 rs764532151 |
174 | V>I | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs530840370 CA31464300 |
177 | S>C | No |
ClinGen TOPMed gnomAD |
|
|
CA31464311 rs367553853 |
178 | S>G | No |
ClinGen ESP |
|
|
rs762161696 CA1230006 |
184 | R>Q | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
rs777036548 CA1230005 |
184 | R>W | No |
ClinGen ExAC gnomAD |
|
|
rs765509729 CA1230007 |
185 | F>V | No |
ClinGen ExAC gnomAD |
|
|
rs1572436980 CA343092676 |
192 | V>G | No |
ClinGen Ensembl |
|
|
rs766282474 CA1230010 |
192 | V>M | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1230012 rs751488353 |
199 | T>K | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs751488353 CA343092840 |
199 | T>M | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA1230011 rs751488353 |
199 | T>R | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
|
rs542882842 CA31464327 |
200 | R>S | No |
ClinGen 1000Genomes ExAC TOPMed gnomAD |
|
|
rs1289504737 CA343092948 |
203 | H>Y | No |
ClinGen gnomAD |
|
| rs1247053027 | 205 | A>= | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1186262130 CA343093830 |
205 | A>T | No |
ClinGen gnomAD |
|
|
CA1230032 rs751552308 |
208 | T>A | No |
ClinGen ExAC gnomAD |
|
|
rs759490884 CA1230033 |
209 | Y>H | No |
ClinGen ExAC gnomAD |
|
|
rs1420138780 CA343093869 |
210 | M>I | No |
ClinGen gnomAD |
|
|
CA1230034 rs765306922 |
210 | M>L | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs1325075001 CA343093883 |
212 | R>Q | No |
ClinGen TOPMed |
|
| TCGA novel | 213 | E>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 214 | Y>C | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA1230035 rs752492412 |
215 | T>M | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA343093919 rs1333620722 |
217 | R>Q | No |
ClinGen gnomAD |
|
|
CA343093971 rs1454620575 |
219 | S>N | No |
ClinGen TOPMed gnomAD |
|
|
CA343093981 rs1307436513 |
219 | S>R | No |
ClinGen gnomAD |
|
|
CA1230038 rs753509670 |
220 | K>R | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA TOPMed gnomAD |
| TCGA novel | 222 | S>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA343094129 rs1240230319 |
225 | M>T | No |
ClinGen gnomAD |
|
|
CA343094359 rs1471032314 |
226 | H>R | No |
ClinGen gnomAD |
|
|
rs1348389554 CA343094391 |
228 | P>L | No |
ClinGen TOPMed |
|
|
CA1230051 rs144016855 |
229 | P>R | No |
ClinGen ESP ExAC gnomAD |
|
|
CA1230053 rs760512618 |
230 | S>F | No |
ClinGen ExAC gnomAD |
|
|
rs1038788182 CA31466200 |
231 | L>H | No |
ClinGen TOPMed |
|
|
CA1230054 rs763920417 |
231 | L>V | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA343094468 rs1326202616 |
233 | T>M | No |
ClinGen gnomAD |
|
|
CA343094509 rs1427059050 |
235 | P>R | No |
ClinGen TOPMed |
|
|
CA1230056 rs756959228 |
238 | I>K | No |
ClinGen ExAC gnomAD |
|
|
rs779054395 CA1230057 |
239 | S>F | No |
ClinGen ExAC gnomAD |
|
|
CA1230058 rs749962048 |
240 | Q>R | No |
ClinGen ExAC gnomAD |
|
|
CA1230060 rs781775909 |
247 | A>T | No |
ClinGen ExAC TOPMed gnomAD |
|
|
rs748631632 CA1230061 |
249 | C>G | No |
ClinGen ExAC gnomAD |
|
|
rs1250770452 CA343095002 |
253 | I>R | No |
ClinGen TOPMed |
|
|
rs1558166866 CA343094990 |
253 | I>V | No |
ClinGen Ensembl |
|
|
rs746302570 CA31466228 |
257 | R>K | No |
ClinGen TOPMed |
|
|
rs368864556 CA1230065 |
264 | D>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA343095222 rs1314276870 |
266 | Q>H | No |
ClinGen TOPMed |
|
|
rs771188615 CA1230066 |
266 | Q>K | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 267 | K>R | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA343095252 rs1386576626 |
268 | S>G | No |
ClinGen gnomAD |
|
| TCGA novel | 268 | S>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs892544453 CA343095261 |
268 | S>R | No |
ClinGen gnomAD |
|
|
rs1302365354 CA343095273 |
269 | T>A | No |
ClinGen TOPMed |
|
|
CA343095310 rs1372338072 |
271 | V>M | No |
ClinGen gnomAD |
No associated diseases with O75663
No regional properties for O75663
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for O75663 | |||
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
No GO annotations of molecular function
| Name | Definition |
|---|---|
| No GO annotations for molecular function |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| DNA damage checkpoint signaling | A signal transduction process that contributes to a DNA damage checkpoint. |
| negative regulation of phosphoprotein phosphatase activity | Any process that stops or reduces the activity of a phosphoprotein phosphatase. |
| regulation of phosphoprotein phosphatase activity | Any process that modulates the frequency, rate or extent of phosphoprotein phosphatase activity, the catalysis of the hydrolysis of phosphate from a phosphoprotein. |
| TOR signaling | The series of molecular signals mediated by TOR (Target of rapamycin) proteins, members of the phosphoinositide (PI) 3-kinase related kinase (PIKK) family that act as serine/threonine kinases in response to nutrient availability or growth factors. |
1 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P34274 | C02C2.6 | TIP41-like protein | Caenorhabditis elegans | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MMIHGFQSSH | RDFCFGPWKL | TASKTHIMKS | ADVEKLADEL | HMPSLPEMMF | GDNVLRIQHG |
| 70 | 80 | 90 | 100 | 110 | 120 |
| SGFGIEFNAT | DALRCVNNYQ | GMLKVACAEE | WQESRTEGEH | SKEVIKPYDW | TYTTDYKGTL |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LGESLKLKVV | PTTDHIDTEK | LKAREQIKFF | EEVLLFEDEL | HDHGVSSLSV | KIRVMPSSFF |
| 190 | 200 | 210 | 220 | 230 | 240 |
| LLLRFFLRID | GVLIRMNDTR | LYHEADKTYM | LREYTSRESK | ISSLMHVPPS | LFTEPNEISQ |
| 250 | 260 | 270 | |||
| YLPIKEAVCE | KLIFPERIDP | NPADSQKSTQ | VE |